The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Locoregional control, failure patterns and clinical outcomes in patients with stage III non-small cell lung cancers treated with chemoradiation and durvalumab.
 
Michael Offin
Consulting or Advisory Role - Novartis; PharmaMar; Targeted Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Narek Shaverdian
No Relationships to Disclose
 
Andreas Rimner
Consulting or Advisory Role - AstraZeneca; Cybrexa Therapeutics; Merck; MORE Health; Varian Medical Systems
Research Funding - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Varian Medical Systems
Travel, Accommodations, Expenses - Philips/Elekta
 
Stephanie Lobaugh
No Relationships to Disclose
 
Annemarie Shepherd
Consulting or Advisory Role - ASCO
Travel, Accommodations, Expenses - ASCO
 
Charles B. Simone
Honoraria - Varian Medical Systems
 
Daphna Y. Gelblum
No Relationships to Disclose
 
Abraham Jing-Ching Wu
Consulting or Advisory Role - AstraZeneca; MORE Health
Research Funding - CivaTech Oncology
Travel, Accommodations, Expenses - Alpha Tau; CivaTech Oncology
 
Nancy Y. Lee
Stock and Other Ownership Interests - Advanced Genomic Solutions (I)
Consulting or Advisory Role - Intuitive Surgical; Lilly; Merck; PDS Biotechnology; Pfizer; Vertex
Research Funding - Regeneron
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Pfizer
Other Relationship - Memorial Sloan-Kettering Cancer Center
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Amgen; Ascentage Pharma; AstraZeneca; Bicycle Therapeutics; Bridge Medicines; Celgene; Daiichi Sankyo; Genentech/Roche; Harpoon Therapeutics; Ipsen; Loxo; PharmaMar; PharmaMar
Research Funding - Abbvie/Stemcentrx (Inst); Daiichi Sankyo (Inst); Merck (Inst); Viralytics (Inst)
 
Zhigang Zhang
No Relationships to Disclose
 
Matthew David Hellmann
Stock and Other Ownership Interests - Immunai; Shattuck Labs
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca/MedImmune; Blueprint Medicines; Bristol-Myers Squibb; Genentech; Immunai; Merck; Mirati Therapeutics; Nektar; Shattuck Labs; Syndax
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - A patent has been filed by Memorial Sloan Kettering (PCT/US2015/062208) for the use of tumor mutation burden for prediction of immunotherapy efficacy, and which is licensed to Personal Genome Diagnostics. (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst)
 
Daniel Richard Gomez
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; Reflexion Medical; US Oncology; Varian Medical Systems; Vindico Medical Education
Speakers' Bureau - Bristol-Myers Squibb; Varian Medical Systems
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck; Varian Medical Systems
Travel, Accommodations, Expenses - AstraZeneca; Driver, Inc; Merck; US Oncology; Varian Medical Systems; Vindico Medical Education